Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-25-012263
Filing Date
2025-08-14
Accepted
2025-08-14 16:10:49
Documents
2
Period of Report
2025-08-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-70293.html 3  
1 PRIMARY DOCUMENT marketforms-70293.xml 3 1814
2 POA DOCUMENT poa.htm EX-24 4500
  Complete submission text file 0001214659-25-012263.txt   8071
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XOMA ROYALTY CORPORATION 2200 POWELL STREET, SUITE 310 EMERYVILLE CA 94608
Business Address
Montano Maricel Perea (Reporting) CIK: 0002076299 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39801 | Film No.: 251219085